Drug Profile
JNJ 38893777
Alternative Names: JNJ-38893777Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Janssen Research & Development
- Class Analgesics; Piperidines; Pyridines; Small molecules
- Mechanism of Action TRPV1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain